Clinical pharmacokinetics and metabolism of chloroquine

Discussion in 'Canadian Drug' started by JOker__92, 25-Feb-2020.

  1. omut New Member

    Clinical pharmacokinetics and metabolism of chloroquine


    Tablet, Oral, as phosphate: Generic: 250 mg [equivalent to chloroquine base 150 mg], 500 mg [equivalent to chloroquine base 300 mg] Binds to and inhibits DNA and RNA polymerase; interferes with metabolism and hemoglobin utilization by parasites; inhibits prostaglandin effects; chloroquine concentrates within parasite acid vesicles and raises internal p H resulting in inhibition of parasite growth; may involve aggregates of ferriprotoporphyrin IX acting as chloroquine receptors causing membrane damage; may also interfere with nucleoprotein synthesis Rapid and almost complete Widely in body tissues including eyes, heart, kidneys, liver, leukocytes, and lungs where retention is prolonged Partially hepatic to main metabolite, desethylchloroquine Urine (~70%; ~35% as unchanged drug); acidification of urine increases elimination; small amounts of drug may be present in urine months following discontinuation of therapy Serum: Oral: Within 1-2 hours 3 to 5 days ~55% Malaria: Treatment of uncomplicated malaria due to susceptible strains of Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium falciparum; prophylaxis of malaria (in geographic areas where chloroquine resistance is not present). Limitations of use: Chloroquine does not prevent relapses in patients with vivax or ovale malaria (not effective against exoerythrocytic forms). Extraintestinal amebiasis: Treatment of extraintestinal amebiasis. Data from a prospective, randomized, controlled, double-blind clinical trial supports the use of chloroquine in the treatment of discoid lupus erythematosus .

    Sides effects of hydroxychloroquine Does plaquenil have small amounts of malaria in it Does hydroxychloroquine lower your immune system

    There is differential binding and metabolism of the R and S stereoisomers. Both drugs bind strongly to pigmented tissues but also bind to mononuclear cells, muscles, etc. Clinical Pharmacokinetics of Antimalerial Drugs. Pharmacokinetics of chloroquine saliva and plasma levels relationship. Eur J Drug Metab Pharmacokin 1986; 11. The cytochrome P450 enzymes CYP2D6 17, 19 and CYP2C8 are known to participate in the metabolism of the primaquine and chloroquine, respectively. Two SNPs G416Ars11572080 and A805T rs11572103 were genotyped in the CYP2C8 gene. The effect of antimalarial drugs on other drugs and vice versa is an important clinical consideration. Both chloroquine and hydroxychloroquine are substrates for cytochrome P450 CYP enzymes.

    Hypersensitivity to chloroquine, 4-aminoquinoline compounds, or any component of the formulation; the presence of retinal or visual field changes of any etiology (when used for indications other than acute malaria) Note: Chloroquine is currently under investigation for use in the treatment of COVID-19. Do not use for the treatment of complicated malaria (high-grade parasitemia and/or complications [eg, cerebral malaria, acute renal failure]) or for malaria prophylaxis in areas where chloroquine resistance occurs (resistance to chloroquine is widespread in P. Additional data may be necessary to further define the role of chloroquine in the treatment of this condition.

    Clinical pharmacokinetics and metabolism of chloroquine

    PDF Studies on the pharmacokinetics of Primaquine, Pharmacokinetics/pharmacodynamics of chloroquine and.

  2. What does chloroquine treat
  3. Plaquenil increased gas
  4. Ducharme J, Farinotti R Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet. 1996 Oct;314257-74. doi 10.2165/00003088-199631040-00003.

    • Reaction Chloroquine to 1 product - DrugBank.
    • Mechanisms of action of hydroxychloroquine and chloroquine..
    • Clinical Pharmacokinetics of Antimalarial Drugs SpringerLink.

    Metabolism Chloroquine undergoes metabolism by hepatic mechanisms. The main active metabolite is desethylchloroquine. Plasma half-life of desethylchloroquine is similar to chloroquine. The main processes involved in pharmacokinetics are absorption, distribution, and the two routes of drug elimination, metabolism and excretion. Together they are sometimes known by the acronym ‘ADME’. Distribution, metabolism and excretion are sometimes referred to collectively as drug disposition. Chloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Occasionally it is used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus.

     
  5. maxmut User

    In some cases, they may not be available in every strength or form as the brand-name drug. Which Drugs Cause Weight Gain, Loss in RA? - U. S. Medicine Plaquenil and Weight gain DailyStrength Rx Side Effects New Plaquenil Guidelines and More.
     
  6. Apostroff XenForo Moderator

    Chloroquine Resistance in Plasmodium falciparum - microbewiki The general accepted conclusion is that chloroquine interferes with the process in which heme is converted to hemozoin 10. Chloroquine concentrates in the food vacuole up to 1000-fold. Chloroquine, exists in unprotonated form, CQ, monoprotonated form, CQ + and diprotonated form, CQ ++ form 13. Unprotonated form of chloroquine is membrane.

    Chloroquine Oral Uses, Side Effects, Interactions.
     
  7. ASh User

    Plaquenil Screening - Retinal Diagnostic Center The goal for Plaquenil Screening to detect toxicity early and stop the medication as soon as possible if present. Functional test that focus on central field sensitivity may pick up early toxicity. Early structural changes may be difficult to detect and high resolution optical coherence tomography.

    Hydroxychloroquine Plaquenil MPKB